Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BDTX

Black Diamond Therapeutics Inc

Dec 11 • 04:00PM ET

2.52

Dollar change +0.08
Percentage change 3.28	%

Healthcare • Biotechnology • USA • NASD

Peers: BPMC FATE IGMS ALLO ADAP CARA XFOR CRBP

| Held by: VTI IWM VXF IWO VTWO FESM IWN IWC DFAC DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.36	Insider Own	24.20%	Shs Outstand	56.52M	Perf Week	2.44%
Market Cap	142.59M	Forward P/E	-	EPS next Y	-1.22	Insider Trans	-1.59%	Shs Float	42.89M	Perf Month	-25.44%
Income	-73.10M	PEG	-	EPS next Q	-0.31	Inst Own	75.31%	Short Float	14.28%	Perf Quarter	-56.92%
Sales	0.00M	P/S	-	EPS this Y	30.85%	Inst Trans	4.94%	Short Ratio	5.20	Perf Half Y	-59.62%
Book/sh	1.72	P/B	1.46	EPS next Y	5.93%	ROA	-47.12%	Short Interest	6.13M	Perf Year	-15.72%
Cash/sh	1.99	P/C	1.27	EPS next 5Y	-	ROE	-63.09%	52W Range	2.31 - 7.66	Perf YTD	-10.32%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-49.79%	ROI	-62.43%	52W High	-67.10%	Beta	2.48
Dividend TTM	-	Quick Ratio	5.55	Sales past 5Y	0.00%	Gross Margin	-	52W Low	9.09%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	5.55	EPS Y/Y TTM	35.89%	Oper. Margin	-	RSI (14)	41.74	Volatility	6.99% 7.11%
Employees	54	Debt/Eq	0.24	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.14	Target Price	14.50
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	39.04%	Payout	-	Rel Volume	0.35	Prev Close	2.44
Sales Surprise	-	EPS Surprise	24.99%	Sales Q/Q	-	Earnings	Nov 05 BMO	Avg Volume	1.18M	Price	2.52
SMA20	-0.94%	SMA50	-15.50%	SMA200	-46.54%	Trades		Volume	409,844	Change	3.28%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	Raymond James	Outperform	$20
Jul-14-23	Initiated	Piper Sandler	Overweight
Jun-30-23	Upgrade	Stifel	Hold → Buy	$2 → $10
Jun-28-23	Upgrade	H.C. Wainwright	Neutral → Buy	$11
Jun-27-23	Upgrade	Wedbush	Neutral → Outperform	$10
Mar-29-22	Downgrade	Wedbush	Outperform → Neutral
Mar-22-22	Downgrade	H.C. Wainwright	Buy → Neutral
Sep-30-21	Initiated	Stifel	Hold	$10
Jan-07-21	Initiated	Wedbush	Outperform	$45
Nov-24-20	Initiated	Berenberg	Buy	$58
May-04-20	Initiated	H.C. Wainwright	Buy	$53
Feb-24-20	Initiated	JP Morgan	Overweight	$42
Feb-24-20	Initiated	Jefferies	Buy
Feb-24-20	Initiated	Cowen	Outperform
Feb-24-20	Initiated	Canaccord Genuity	Buy	$50

Show Previous Ratings

Nov-05-24 09:00AM	Black Diamond: Q3 Earnings Snapshot (Associated Press Finance) +8.70%
08:00AM	Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-01-24 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.47%
Oct-07-24 04:01PM	Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway (GlobeNewswire)
Sep-23-24 11:43AM	Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug (Benzinga) -5.46%
07:00AM	Loading…
07:00AM	Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations (GlobeNewswire)
Sep-22-24 10:00AM	Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC (GlobeNewswire)
Sep-14-24 03:30AM	Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024 (GlobeNewswire)
Aug-08-24 04:05PM	Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors (GlobeNewswire) +6.25%
12:00PM	All You Need to Know About Black Diamond (BDTX) Rating Upgrade to Buy (Zacks)
Aug-06-24 01:53PM	BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q2 2024 (InvestorPlace) -5.57%
07:37AM	Black Diamond: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Jun-29-24 08:28PM	Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now? (Insider Monkey)
06:30PM	10 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
10:00AM	Loading…
Jun-01-24 10:00AM	Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-29-24 08:00AM	Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-16-24 08:23AM	HC Wainwright Adjusts Price Target on Black Diamond Therapeutics to $11 From $12, Keeps Buy Rating (MT Newswires)
May-10-24 08:46AM	Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings? (Zacks) -9.48%
May-09-24 01:54PM	BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q1 2024 (InvestorPlace)
07:30AM	Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
07:28AM	Black Diamond: Q1 Earnings Snapshot (Associated Press Finance)
Apr-29-24 08:50AM	Black Diamond (BDTX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Apr-25-24 09:55AM	Does Black Diamond (BDTX) Have the Potential to Rally 152.96% as Wall Street Analysts Expect? (Zacks)
Apr-24-24 04:05PM	Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-23-24 07:45AM	Garry Menzel joins GHO Capital as Operating Partner (GlobeNewswire)
Apr-15-24 12:00PM	Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Apr-11-24 08:00AM	Black Diamond Therapeutics Announces Changes to Board of Directors (GlobeNewswire) +11.85%
Apr-08-24 09:55AM	Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know (Zacks) +5.73%
Apr-07-24 06:00PM	Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting (GlobeNewswire)
08:00AM	Loading…
Apr-03-24 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.71%
Mar-22-24 09:55AM	How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93% (Zacks) +6.10%
Mar-14-24 05:31AM	Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ... (GuruFocus.com) +8.35%
Mar-12-24 08:32AM	Black Diamond: Q4 Earnings Snapshot (Associated Press Finance) -5.50%
08:00AM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-05-24 04:30PM	Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 (GlobeNewswire)
Feb-28-24 08:00AM	Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Jan-04-24 08:00AM	Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones (GlobeNewswire)
Dec-13-23 07:00AM	Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM (GlobeNewswire) -9.03%
Nov-07-23 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-06-23 08:07AM	Black Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update (GuruFocus.com)
07:48AM	Black Diamond: Q3 Earnings Snapshot (Associated Press Finance)
07:45AM	Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-20-23 12:54PM	Hedge Fund and Insider Trading News: John Paulson, Sanjay Shah, Doug Kass, Point72 Asset Management, Balyasny Asset Management, Black Diamond Therapeutics, Inc. (BDTX), Delta Air Lines, Inc. (DAL), and More (Insider Monkey)
Oct-14-23 12:30PM	Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535 (GlobeNewswire)
Oct-04-23 12:14PM	Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) -5.56%
Sep-18-23 12:34PM	Co-founder of cancer biotech Black Diamond replaced as CEO (American City Business Journals)
07:00AM	Black Diamond Therapeutics Announces CEO Transition (GlobeNewswire)
Sep-11-23 08:00AM	Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer (GlobeNewswire)
Sep-05-23 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-11-23 07:35AM	Black Diamond: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-25-23 07:43AM	Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jul-16-23 10:05AM	TipRanks Perfect 10 List: These Monster Growth Stocks Could Reach New Highs (TipRanks)
Jun-29-23 08:57PM	Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -12.22%
05:48PM	Why Shares of Black Diamond Therapeutics Skyrocketed This Week (Motley Fool)
Jun-28-23 04:23PM	Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire) -7.28%
07:15AM	Institutions profited after Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) market cap rose US$152m last week but private equity firms profited the most (Simply Wall St.)
Jun-27-23 07:00AM	Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families (GlobeNewswire) +235.87%
Jun-13-23 08:00AM	Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer (GlobeNewswire) +5.34%
Jun-02-23 08:00AM	Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire) +8.84%
May-18-23 10:17AM	Black Diamond Therapeutics Insider Ups Holding By 82% During Year \ (Simply Wall St.) -6.36%
May-09-23 07:46AM	Black Diamond: Q1 Earnings Snapshot (AP Finance) -5.21%
07:30AM	Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-18-23 08:00AM	Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days (GlobeNewswire)
Apr-17-23 04:01PM	Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting (GlobeNewswire)
Mar-09-23 07:52AM	Black Diamond: Q4 Earnings Snapshot (AP Finance) -13.69%
07:30AM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-27-23 08:00AM	Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire) -9.31%
Feb-15-23 05:46AM	Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth? (Simply Wall St.) -7.72%
Jan-19-23 05:41AM	private equity firms who own 40% along with institutions invested in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) saw increase in their holdings value last week (Simply Wall St.)
Jan-05-23 08:00AM	Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-22 08:00AM	Black Diamond Therapeutics Announces Changes to Board of Directors (GlobeNewswire)
Dec-12-22 08:00AM	Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company (GlobeNewswire)
Dec-09-22 09:35AM	Down 32.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX) (Zacks)
09:04AM	Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) recent US$17m market cap decline means a loss of US$21k for insiders who bought this year (Simply Wall St.)
Nov-09-22 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.70%
Nov-08-22 08:00AM	Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-26-22 08:00AM	Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Sep-06-22 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.51%
Aug-28-22 09:41AM	We Think Black Diamond Therapeutics (NASDAQ:BDTX) Needs To Drive Business Growth Carefully (Simply Wall St.)
Aug-09-22 08:00AM	Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-22 08:00AM	Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference (GlobeNewswire)
Aug-01-22 08:55AM	Could The Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Jul-02-22 08:29AM	CFO, Principal Financial Officer and Chief Business Officer Fang Ni Just Bought 57% More Shares In Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) (Simply Wall St.)
Jun-06-22 08:00AM	Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
Jun-01-22 07:00AM	Black Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer (GlobeNewswire)
May-17-22 07:00AM	Black Diamond Therapeutics to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +5.91%
May-12-22 04:30PM	Black Diamond Therapeutics Announces Publication of New Computational and Functional Analyses of HER2 Mutations Based on its Proprietary MAP Discovery Engine (GlobeNewswire)
May-11-22 04:30PM	Black Diamond Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -7.88%
Apr-28-22 12:52PM	Two years after massive IPO, cancer startup makes workforce cuts (American City Business Journals)
Apr-25-22 09:00AM	Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment (GlobeNewswire)
Apr-18-22 07:00AM	Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer (GlobeNewswire)
Apr-07-22 04:30PM	Black Diamond Therapeutics to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference (GlobeNewswire) +14.14%
07:00AM	Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors (GlobeNewswire)
Mar-17-22 05:00PM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-02-22 08:00AM	Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-22-22 08:00AM	Black Diamond Therapeutics Appoints Elizabeth Montgomery as Chief People Officer (GlobeNewswire) -5.65%
Feb-16-22 05:28AM	Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely? (Simply Wall St.)

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Versant Venture Capital VI, L.	10% Owner	Aug 28 '24	Sale	6.32	221,600	1,400,556	3,726,341	Aug 30 04:16 PM
David Epstein	Former Employer	Jul 31 '24	Proposed Sale	6.20	50,000	310,000		Jul 31 04:18 PM
David Epstein	Former Employee	Jul 26 '24	Proposed Sale	6.20	50,000	310,000		Jul 26 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BDTX

Black Diamond Therapeutics Inc

Upgrade your FINVIZ experience